DK2397480T3 - Diazepindionderivat - Google Patents

Diazepindionderivat

Info

Publication number
DK2397480T3
DK2397480T3 DK10741334.6T DK10741334T DK2397480T3 DK 2397480 T3 DK2397480 T3 DK 2397480T3 DK 10741334 T DK10741334 T DK 10741334T DK 2397480 T3 DK2397480 T3 DK 2397480T3
Authority
DK
Denmark
Prior art keywords
diazepindion
derivatives
diazepindion derivatives
Prior art date
Application number
DK10741334.6T
Other languages
English (en)
Inventor
Shogo Sakuma
Toshihiro Takahashi
Masatoshi Ushioda
Toshiyasu Imai
Kazuhide Inoue
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Application granted granted Critical
Publication of DK2397480T3 publication Critical patent/DK2397480T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK10741334.6T 2009-02-16 2010-02-15 Diazepindionderivat DK2397480T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009032705 2009-02-16
PCT/JP2010/052571 WO2010093061A1 (ja) 2009-02-16 2010-02-15 ジアゼピンジオン誘導体

Publications (1)

Publication Number Publication Date
DK2397480T3 true DK2397480T3 (da) 2013-09-02

Family

ID=42561898

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10741334.6T DK2397480T3 (da) 2009-02-16 2010-02-15 Diazepindionderivat

Country Status (10)

Country Link
US (2) US8470814B2 (da)
EP (1) EP2397480B1 (da)
JP (1) JP5592278B2 (da)
KR (1) KR101727761B1 (da)
CN (1) CN102395577B (da)
CA (1) CA2789641C (da)
DK (1) DK2397480T3 (da)
ES (1) ES2432265T3 (da)
PL (1) PL2397480T3 (da)
WO (1) WO2010093061A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012008478A1 (ja) * 2010-07-13 2012-01-19 日本ケミファ株式会社 P2x4受容体拮抗剤
WO2012014910A1 (ja) * 2010-07-29 2012-02-02 日本ケミファ株式会社 P2x4受容体拮抗剤
US9115123B2 (en) * 2010-11-05 2015-08-25 Kyushu University Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
ES2653244T3 (es) * 2011-05-25 2018-02-06 Nippon Chemiphar Co., Ltd. Agente profiláctico o terapéutico para dolor neuropático asociado al Síndrome de Guillain-Barré
DK2803662T3 (da) 2012-01-13 2017-05-01 Nippon Chemiphar Co P2X4-receptorantagonist
US10150744B2 (en) 2013-07-12 2018-12-11 Nippon Chemiphar Co., Ltd P2X4 receptor antagonist
CA2921203C (en) 2013-07-12 2021-07-27 Nippon Chemiphar Co., Ltd. Diazepinedione derivatives and compositions thereof useful as p2x4 receptor antagonist
BR112016025450A2 (pt) 2014-05-02 2017-12-12 Medimmune Ltd moduladores de canais de íons e usos dos mesmos
CN109414503A (zh) * 2016-04-28 2019-03-01 日本化学药品株式会社 用于多发性硬化症的治疗的医药品
US10695355B2 (en) * 2017-03-30 2020-06-30 University Of Connecticut Methods for pharmacologic treatment of stroke
JP7374882B2 (ja) * 2018-03-14 2023-11-07 日本ケミファ株式会社 咳嗽の治療のための医薬
EP3848051A4 (en) * 2018-09-03 2022-06-08 Nippon Chemiphar Co., Ltd. DRUG TARGETING DIABETIC PERIPHERAL NEUROPATHY
JP2022163241A (ja) * 2019-09-13 2022-10-26 日本ケミファ株式会社 P2x4受容体拮抗剤
AU2020439775A1 (en) * 2020-03-30 2022-11-03 Nippon Chemiphar Co., Ltd. Medicament for use in preventing or treating irritable bowel syndrome or inflammatory bowel disease
AU2021301158A1 (en) * 2020-06-30 2022-12-15 Bayer Aktiengesellschaft Use of N-phenylacetamides having P2X4 receptor antagonistic activity for treating certain ocular disorders
JP7621619B2 (ja) 2020-08-03 2025-01-27 日本ケミファ株式会社 アレルギー反応に伴う症状の予防若しくは抑制又は治療用の医薬組成物
IT202100025124A1 (it) 2021-09-30 2023-03-30 Univ Degli Studi Di Firenze Medicamento per uso nel prevenire o trattare il dolore nocicettivo e/o viscerale
EP4410310A4 (en) 2021-09-30 2025-10-22 Nippon Chemiphar Co PROPHYLACTIC OR THERAPEUTIC AGENT FOR RESPIRATORY DISEASES
JP2025041993A (ja) * 2022-02-17 2025-03-27 国立大学法人鳥取大学 子宮内膜症又は子宮腺筋症の予防又は治療剤
AU2023244778A1 (en) 2022-03-31 2024-10-17 Nippon Chemiphar Co., Ltd. Pharmaceutical composition for preventing or suppressing or treating symptoms accompanying pseudo-allergic reactions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4969105A (en) 1988-05-02 1990-11-06 Ingersoll-Rand Company Gasket compression control method having tension-related feedback
DE10312969A1 (de) * 2003-03-24 2004-10-07 Bayer Healthcare Ag Benzofuro-1,4-diazepin-2-on-Derivate
CA2444161A1 (en) 2003-10-01 2005-04-01 Japan Health Sciences Foundation A screening method of drug for treatment of neuropathic pain
JP2009057281A (ja) 2005-12-19 2009-03-19 Nippon Chemiphar Co Ltd P2x4受容体拮抗剤
JP2009062278A (ja) * 2005-12-29 2009-03-26 Nippon Chemiphar Co Ltd P2x4受容体拮抗剤
JPWO2008023847A1 (ja) 2006-08-25 2010-01-14 日本ケミファ株式会社 P2x4受容体拮抗剤

Also Published As

Publication number Publication date
US20130281441A1 (en) 2013-10-24
EP2397480A4 (en) 2012-07-25
KR20110120939A (ko) 2011-11-04
PL2397480T3 (pl) 2014-01-31
WO2010093061A1 (ja) 2010-08-19
CN102395577A (zh) 2012-03-28
CN102395577B (zh) 2014-04-23
JP5592278B2 (ja) 2014-09-17
CA2789641A1 (en) 2010-08-19
US8778933B2 (en) 2014-07-15
US8470814B2 (en) 2013-06-25
KR101727761B1 (ko) 2017-04-17
EP2397480A1 (en) 2011-12-21
CA2789641C (en) 2018-03-13
EP2397480B1 (en) 2013-08-14
ES2432265T3 (es) 2013-12-02
JPWO2010093061A1 (ja) 2012-08-16
US20110319610A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
ECSP12011999A (es) Derivados benzamida sustituidos
DK2414015T3 (da) Laryngoskopsystem
DK2411442T4 (da) Umættet polyesterresin
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
DK2397480T3 (da) Diazepindionderivat
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1013844A2 (pt) derivados de piridina-isoxazol
EP2433940A4 (en) SPIROIMIDAZOLONDERIVAT
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
DE112010004249A5 (de) Spindelaktor
DE112009005323A5 (de) Hebelarmprüfmaschine
DK2387580T3 (da) Deoxyactagardinderivater
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero
DK2483126T3 (da) Skinnekøretøj
EP2401281A4 (en) PYRIMIDINPYRIMIDOINDAZOLDERIVAT
BRPI1011416A2 (pt) derivados de antraquinova novos